Back to
Mackenzie Financial Corp.
ROIV
3 quarters
Position history for
Mackenzie Financial Corp.'s holdings in Roivant Sciences Ltd.
No. Mackenzie Financial exited its ROIV (Roivant Sciences) position in Q3 2023. Its Q2 2023 13F listed 23,456 shares worth $228,931. Mackenzie Financial first reported ROIV in Q1 2023 and held it in 2 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$304,019
Total Shares Change
-41,195
Quarter-by-Quarter History
Other major holders of ROIV: FMR LLC, BlackRock, Inc., Morgan Stanley